0000899243-20-007719.txt : 20200310
0000899243-20-007719.hdr.sgml : 20200310
20200310141004
ACCESSION NUMBER: 0000899243-20-007719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200306
FILED AS OF DATE: 20200310
DATE AS OF CHANGE: 20200310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DArecca James
CENTRAL INDEX KEY: 0001583903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36867
FILM NUMBER: 20700956
MAIL ADDRESS:
STREET 1: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allergan plc
CENTRAL INDEX KEY: 0001578845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
BUSINESS PHONE: (216) 523-5000
MAIL ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis plc
DATE OF NAME CHANGE: 20130930
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis Ltd
DATE OF NAME CHANGE: 20130607
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-06
0
0001578845
Allergan plc
AGN
0001583903
DArecca James
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK,
COOLOCK, CO.
DUBLIN
L2
D17 E400
IRELAND
0
1
0
0
SVP Chief Accounting Officer
Ordinary Shares, par value $0.0001
2020-03-06
4
F
0
718
191.95
D
9834
D
Includes restricted stock units issued pursuant to the Amended and Restated 2013 Incentive Award Plan of Allergan plc.
/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person
2020-03-10